CareDx Strengthens Leadership Team to Accelerate Growth
SOUTH SAN FRANCISCO, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on […]
Novavax to Participate in Upcoming Investor Conferences
GAITHERSBURG, Md., Sept. 10, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines […]
GW Pharmaceuticals Announces the Appointment of David Gryska to its Board of Directors
LONDON, Sept. 10, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and […]
Athenex, Inc. Announces Pricing of $110 Million Public Offering of Common Stock
BUFFALO, N.Y., Sept. 10, 2020 (GLOBE NEWSWIRE) — Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, […]
Immatics Provides Update on IMA204 ACTengine® Cell Therapy Program Targeting the Tumor Microenvironment
Tuebingen, Germany and Houston, Texas, Sept. 10, 2020 (GLOBE NEWSWIRE) —IMA204 ACTengine® cell therapy program directed at novel tumor target […]
Abacus Announces Geophysical Program at Jersey Valley
VANCOUVER, British Columbia, Sept. 10, 2020 (GLOBE NEWSWIRE) — Abacus Mining & Exploration Corporation (“Abacus” or the “Company”) (TSXV: AME) […]
Norseman Capital Ltd. Appoints Sean Hurd as CEO, David Robinson as CFO, and John Campbell Smyth as Chairman
VANCOUVER, British Columbia, Sept. 10, 2020 (GLOBE NEWSWIRE) — Norseman Capital Ltd. (TSXV: NOC) (“Norseman” or the “Company”) announces that, […]
Matinas BioPharma to Participate on Anti-Fungal CEO Panel During the M-VEST Virtual Conference Series Sponsored by Maxim Group
BEDMINSTER, N.J., Sept. 10, 2020 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that Jerome D. […]
XPO Logistics Extends Technology Partnership with MIT Industrial Liaison Program
GREENWICH, Conn., Sept. 10, 2020 (GLOBE NEWSWIRE) — XPO Logistics, Inc. (NYSE: XPO), a leading global provider of transportation and […]
Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences
NEW YORK and SAN DIEGO, Sept. 10, 2020 (GLOBE NEWSWIRE) — Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company […]
